SCHEMBL12694807

SCHEMBL12694807

CCN1CC(C)(C)Oc2ccc(Nc3nc(Nc4ccc(N5CCN(C)CC5)cc4)ncc3Cl)cc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 14/20 0.63
▸ ALK Q9UM73 2/20 0.58
▸ CDK9 P50750 3/20 0.56
▸ CHEK1 O14757 1/20 0.56
▸ AURKA O14965 1/20 0.56
▸ DAPK3 O43293 1/20 0.56
▸ JAK2 O60674 1/20 0.56
▸ PRKD3 O94806 1/20 0.56
▸ MAP4K4 O95819 1/20 0.56
▸ PAK4 O96013 1/20 0.56
▸ ABL1 P00519 1/20 0.56
▸ NTRK1 P04629 1/20 0.56
▸ LCK P06239 1/20 0.56
▸ FYN P06241 1/20 0.56
▸ CSF1R P07333 1/20 0.56
▸ RET P07949 1/20 0.56
▸ IGF1R P08069 1/20 0.56
▸ MET P08581 1/20 0.56
▸ PDGFRB P09619 1/20 0.56
▸ PIM1 P11309 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12694650 0.93 ALK (0.61) BRD4ALKCDK9CHEK1AURKA
SCHEMBL12854593 0.85 BRD4 (0.62) BRD4ALKCDK9CHEK1AURKA
SCHEMBL3112812 0.82 BRD4 (0.61) BRD4ALKCDK9CHEK1AURKA
SCHEMBL3107379 0.82 BRD4 (0.65) BRD4ALKCDK9CHEK1AURKA
SCHEMBL12694656 0.82 CTSC (0.61) BRD4ALKCDK9CHEK1AURKA
SCHEMBL3110197 0.81 BRD4 (0.62) BRD4ALKCDK9CHEK1AURKA
SCHEMBL3109212 0.81 BRD4 (0.61) BRD4ALKCDK9CHEK1AURKA
SCHEMBL12694698 0.80 BRD4 (0.53) BRD4ALKCDK9CHEK1AURKA
SCHEMBL12694654 0.79 BRD4 (0.72) BRD4ALKCDK9CHEK1AURKA
SCHEMBL12854603 0.79 ALK (0.59) BRD4ALKCDK9CHEK1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278299-B2 Pyrimidinediamine kinase inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2012-10-02 — — US disclosed
Send feedback